These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 37224301)

  • 21. Costs of inflammatory bowel disease in Germany.
    Stark R; König HH; Leidl R
    Pharmacoeconomics; 2006; 24(8):797-814. PubMed ID: 16898849
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Financial Hardship From Medical Bills Among Adults With Chronic Liver Diseases: National Estimates From the United States.
    Lago-Hernandez C; Nguyen NH; Khera R; Loomba R; Asrani SK; Singh S
    Hepatology; 2021 Sep; 74(3):1509-1522. PubMed ID: 33772833
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Financial toxicity of cancer treatment in India: towards closing the cancer care gap.
    Prinja S; Dixit J; Gupta N; Dhankhar A; Kataki AC; Roy PS; Mehra N; Kumar L; Singh A; Malhotra P; Goyal A; Rajsekar K; Krishnamurthy MN; Gupta S
    Front Public Health; 2023; 11():1065737. PubMed ID: 37404274
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Interventions for the management of abdominal pain in Crohn's disease and inflammatory bowel disease.
    Sinopoulou V; Gordon M; Akobeng AK; Gasparetto M; Sammaan M; Vasiliou J; Dovey TM
    Cochrane Database Syst Rev; 2021 Nov; 11(11):CD013531. PubMed ID: 34844288
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The impact of symptom severity on the humanistic and economic burden of inflammatory bowel disease: a real-world data linkage study.
    Naegeli AN; Balkaran BL; Shan M; Hunter TM; Lee LK; Jairath V
    Curr Med Res Opin; 2022 Apr; 38(4):541-551. PubMed ID: 35175166
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Financial Toxicity in Atherosclerotic Cardiovascular Disease in the United States: Current State and Future Directions.
    Khera R; Valero-Elizondo J; Nasir K
    J Am Heart Assoc; 2020 Oct; 9(19):e017793. PubMed ID: 32924728
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Direct health-care cost utilization in Hong Kong inflammatory bowel disease patients in the initial 2 years following diagnosis.
    Mak LY; Ng SC; Wong IOL; Li MKK; Lo FH; Wong MTL; Leung CM; Tsang SWC; Chan KH; Sze SF; Shan EHS; Lam BCY; Hui AJ; Hung IFN; Leung WK
    J Gastroenterol Hepatol; 2018 Jan; 33(1):141-149. PubMed ID: 28475813
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Burden of Crohn's disease in the United States: long-term healthcare and work-loss related costs.
    Manceur AM; Ding Z; Muser E; Obando C; Voelker J; Pilon D; Kinkead F; Lafeuille MH; Lefebvre P
    J Med Econ; 2020 Oct; 23(10):1092-1101. PubMed ID: 32609019
    [TBL] [Abstract][Full Text] [Related]  

  • 29. What Is the Financial Impact of Orthopaedic Sequelae of Intravenous Drug Use on Urban Tertiary-care Centers?
    Dwivedi N; Breslin MA; McDermott A; Lin S; Vallier HA; Tornetta P
    Clin Orthop Relat Res; 2020 Oct; 478(10):2202-2212. PubMed ID: 32667752
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Trends in paediatric inflammatory bowel disease-attributable direct costs: a population-based analysis.
    El-Matary W; Nugent Z; Witt J; Bernstein CN
    Aliment Pharmacol Ther; 2021 Jun; 53(11):1201-1208. PubMed ID: 33836105
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Direct and Indirect Costs of Inflammatory Bowel Disease: Ten Years of Follow-up in a Danish Population-based Inception Cohort.
    Lo B; Vind I; Vester-Andersen MK; Bendtsen F; Burisch J
    J Crohns Colitis; 2020 Jan; 14(1):53-63. PubMed ID: 31076743
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Changes in Direct Healthcare Costs before and after the Diagnosis of Inflammatory Bowel Disease: A Nationwide Population-Based Study.
    Lee J; Im JP; Han K; Kim J; Lee HJ; Chun J; Kim JS
    Gut Liver; 2020 Jan; 14(1):89-99. PubMed ID: 31158951
    [No Abstract]   [Full Text] [Related]  

  • 33. Burden of comorbid anxiety and depression in patients with inflammatory bowel disease: a systematic literature review.
    Dubinsky MC; Dotan I; Rubin DT; Bernauer M; Patel D; Cheung R; Modesto I; Latymer M; Keefer L
    Expert Rev Gastroenterol Hepatol; 2021 Sep; 15(9):985-997. PubMed ID: 34130572
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Economic burden and factors associated with Crohn's disease].
    Zhou WP; Mu N; Jian WY; Wang HH
    Beijing Da Xue Xue Bao Yi Xue Ban; 2021 Jun; 53(3):555-559. PubMed ID: 34145860
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Determinants of Healthcare Utilization Among Veterans with Inflammatory Bowel Disease.
    Tan MC; El-Serag HB; Hou JK
    Dig Dis Sci; 2017 Mar; 62(3):607-614. PubMed ID: 28012103
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Differences in healthcare expenditures for inflammatory bowel disease by insurance status, income, and clinical care setting.
    Park MD; Bhattacharya J; Park K
    PeerJ; 2014; 2():e587. PubMed ID: 25279267
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Direct health care costs of Crohn's disease and ulcerative colitis in US children and adults.
    Kappelman MD; Rifas-Shiman SL; Porter CQ; Ollendorf DA; Sandler RS; Galanko JA; Finkelstein JA
    Gastroenterology; 2008 Dec; 135(6):1907-13. PubMed ID: 18854185
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Impact of a Patient Support Program on Patient Adherence to Adalimumab and Direct Medical Costs in Crohn's Disease, Ulcerative Colitis, Rheumatoid Arthritis, Psoriasis, Psoriatic Arthritis, and Ankylosing Spondylitis.
    Rubin DT; Mittal M; Davis M; Johnson S; Chao J; Skup M
    J Manag Care Spec Pharm; 2017 Aug; 23(8):859-867. PubMed ID: 28737994
    [TBL] [Abstract][Full Text] [Related]  

  • 39. High Disease Burden Drives Indirect Costs in Employed Inflammatory Bowel Disease Patients: The WORK-IBD Study.
    van Gennep S; Evers SW; Rietdijk ST; Gielen ME; de Boer NKH; Gecse KB; Ponsioen CIJ; Duijvestein M; D'Haens GR; de Boer AGEM; Löwenberg M
    Inflamm Bowel Dis; 2021 Feb; 27(3):352-363. PubMed ID: 32378704
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Economic Burden Associated With Untreated Mental Illness in Indiana.
    Taylor HL; Menachemi N; Gilbert A; Chaudhary J; Blackburn J
    JAMA Health Forum; 2023 Oct; 4(10):e233535. PubMed ID: 37831461
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.